AMREP Corporation (NYSE:AXR) reported that it and its indirect subsidiaries, Kable Distribution Services, Inc. (“Kable Distribution”) and Palm Coast Data LLC (“Palm Coast”), have entered into a comprehensive settlement agreement with Heinrich Bauer (USA) LLC (“Bauer”), which resolves all matters relating to the two distribution agreements between Kable Distribution and Bauer that will terminate on June 30, 2014. AMREP Corporation (NYSE:AXR) net profit margin is -3.50% and weekly performance is 28.35%. On last trading day company shares ended up $6.61. AMREP Corporation (NYSE:AXR) distance from 50-day simple moving average (SMA50) is 23.02%.
Shares of Merus Labs International (NASDAQ:MSLI) surged 18.5% on Thursday after the company bolstered the amount of its public offering announced just last night to $27.2 million from $22.1 million initially. The specialty pharmaceutical company, which said it will use the proceeds of the financing for future acquisitions and general working capital, increased the size of the offering by an additional 3.0 million common shares this morning, for a total of 16 million shares at $1.70 apiece.
Merus Labs International Inc (USA) (NASDAQ:MSLI) shares advanced 22.69% in last trading session and ended the day on $2.00.
On June 12, 2014, the Board of Directors (the “Board”) of TG Therapeutics, Inc. (NASDAQ:TGTX) approved a second amendment (the “Second Weiss Amendment”) to the Restricted Stock Agreement of Michael S. Weiss, TG’s Chief Executive Officer, dated as of May 16, 2012 (the “Weiss Restricted Stock Agreement”). TG Therapeutics, Inc. (NASDAQ:TGTX) shares moved up 20.82% in last trading session and was closed at $8.82, while trading in range of $7.19 – $8.89. TG Therapeutics, Inc. (NASDAQ:TGTX) year to date (YTD) performance is 126.15%.
RiceBran Technologies (NASDAQ:RIBT), a global leader in the production and marketing of value added products derived from rice bran, announced that it will be a featured presenter at the 25(th) Annual Institutional Investor Conference of The Wall Street Analyst Forum on Thursday, June 19, 2014 at The University Club in New York City. RiceBran Technologies (NASDAQ:RIBT) ended the last trading day at $6.70. Company weekly volatility is calculated as 6.09% and price to cash ratio as 3.99.RiceBran Technologies (NASDAQ:RIBT) showed a positive weekly performance of 16.72%.
Northwest BioTherapeutics, Inc (NASDAQ:NWBO) reported significantly positive results in its Phase I/II clinical trial involving DCVax-Direct to treat various kinds of inoperable solid tumors. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) weekly performance is 25.92%. On last trading day company shares ended up $7.19. Analysts mean target price for the company is $10.05. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) distance from 50-day simple moving average (SMA50) is 18.67%.